These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Are all antihypertensive drugs renoprotective?]. Wolf S; Risler T Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950 [TBL] [Abstract][Full Text] [Related]
9. Effects of ACE inhibition on renal haemodynamics in essential hypertension and hypertension associated with chronic renal failure. Sánchez RA; Traballi CA; Marcó EJ; Gilbert BH; Ramírez AJ; Long G Drugs; 1991; 41 Suppl 1():25-30. PubMed ID: 1712268 [TBL] [Abstract][Full Text] [Related]
10. [Nephroprotection by inhibition of the renin-angiotensin system--wish or reality?]. Barnas U; Mayer G Wien Klin Wochenschr; 1995; 107(1):10-4. PubMed ID: 7871784 [TBL] [Abstract][Full Text] [Related]
11. Nephroprotective effect of ACE inhibitors. Orth S; Nowicki M; Wiecek A; Ritz E Drugs; 1993; 46 Suppl 2():189-95; discussion 195-6. PubMed ID: 7512474 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibition in renal disease; contrasting effects on renal function in renal artery stenosis and progressive renal injury. Jackson B; Johnston CI J Hum Hypertens; 1989 Jun; 3 Suppl 1():107-15. PubMed ID: 2674436 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic implications of converting-enzyme inhibitors in renal disease. Anderson S; Brenner BM Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):81-7. PubMed ID: 3037894 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. Anderson S; Rennke HG; Brenner BM J Clin Invest; 1986 Jun; 77(6):1993-2000. PubMed ID: 3011863 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic benefit of converting-enzyme inhibition in progressive renal disease. Anderson S; Brenner BM Am J Hypertens; 1988 Oct; 1(4 Pt 2):380S-383S. PubMed ID: 3056448 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibition and renal protection. An assessment of implications for therapy. Hollenberg NK; Raij L Arch Intern Med; 1993 Nov; 153(21):2426-35. PubMed ID: 8215747 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin converting enzyme inhibitors and progression of chronic renal failure. Tolins JP; Raij L Kidney Int Suppl; 1990 Nov; 30():S118-22. PubMed ID: 2259070 [TBL] [Abstract][Full Text] [Related]
18. Progressive renal insufficiency: the role of angiotensin converting enzyme inhibitors. Savage S; Schrier RW Adv Intern Med; 1992; 37():85-101. PubMed ID: 1558007 [TBL] [Abstract][Full Text] [Related]
19. Antihypertensive therapy and the progression of renal disease. Anderson S J Hypertens Suppl; 1989 Sep; 7(7):S39-42. PubMed ID: 2693656 [TBL] [Abstract][Full Text] [Related]
20. ACE inhibitors and the kidney. A risk-benefit assessment. Navis G; Faber HJ; de Zeeuw D; de Jong PE Drug Saf; 1996 Sep; 15(3):200-11. PubMed ID: 8879974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]